Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREAM
2011-003591-37Phase 4Completed
- Sponsor
- Cardiff University
- Start
- Jul 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of flucloxacillin, erythromycin, fusidic acid and corticosteroids in atopic dermatitis (AD) (3 arms), sponsored by Cardiff University. Primary endpoint: Patient-Oriented Eczema Measure at 2 weeks. Started Jul 2012; status: completed.
02
Drugs
flucloxacillinerythromycinfusidic acidcorticosteroids
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-003591-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003591-37.